Data investigation

The Thyroid Test Nobody Reordered

Levothyroxine is dosed by body weight, so losing a lot changes what you need. Across 5,370 matched patients, thyroid testing after starting a GLP-1 was identical to a drug with far smaller weight effects.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
5 min read·1 citation

Levothyroxine dose requirement tracks body weight, so a drug that removes a lot of weight predictably changes the dose someone needs. A 2026 study looked at whether anyone rechecked. Among 5,370 matched patients on stable levothyroxine, thyroid testing after starting a GLP-1 was indistinguishable from testing after starting a drug with far smaller weight effects: the same proportion tested, at the same point.[1]

What was compared

The study emulated a trial using Medicare claims: adults aged 65 and over with type 2 diabetes, on a stable levothyroxine dose, starting either a GLP-1 or an SGLT2 inhibitor, matched one to one on propensity scores. The outcome was simply whether a TSH test was ordered during follow-up.[1]

Thyroid testing after starting each drug class, across 5,370 matched patients.
MeasureGLP-1 receptor agonistsSGLT2 inhibitors
TSH tested within one year~83%~83%
Mean time to testing~130.5 days~130.5 days

The comparator is well chosen. SGLT2 inhibitors also reduce weight, but considerably less than GLP-1 drugs do, so this is not a comparison against no treatment. Two groups whose thyroid-monitoring needs differ were monitored identically.

Eighty-three percent in both arms. One hundred and thirty days in both arms. Nothing moved.

Why it should have moved

Levothyroxine is dosed by body weight, and the therapeutic window is narrow enough that people notice when it is wrong: fatigue and cold intolerance at one end, palpitations and anxiety at the other. Lose a substantial amount of weight and the dose that was correct becomes too much.

There is a second, separate reason specific to the oral GLP-1: taking it alongside levothyroxine raised total thyroxine exposure by 33% in a dedicated trial, which we covered in interactions. That is a pharmacokinetic effect on top of the weight effect, and it applies from the first dose rather than after months of loss. Both effects, and how they interact with the morning dosing rules, are covered in our guide to levothyroxine with a GLP-1.

The authors’ own conclusion names it a gap and a missed opportunity for timely, weight-responsive thyroid monitoring. That is unusually direct language for a claims study. It is aimed at prescribers rather than patients, which is why it helps a patient to know about it.

What the study cannot tell you

  • Whether anyone came to harm. It measured testing, not outcomes. Under-monitoring is a risk, not an injury.
  • The population is narrow: Medicare, aged 65 and over, 71.6% women, 87.1% White, with type 2 diabetes.
  • The period was 2011 to 2020, largely before the modern high-dose weight-loss era. The weight changes involved were smaller than someone on a current dose would experience, which makes the finding conservative rather than weaker.
  • 83% is not bad testing in absolute terms. The finding is not that monitoring was poor; it is that it did not respond to a change in need.

What to do with it

If you take levothyroxine and are starting or already on a GLP-1, this is a reasonable thing to raise: whether your thyroid levels should be rechecked as your weight changes, and when. It is a question rather than a demand, and the answer belongs to whoever manages your thyroid.

It also helps to know what an over-replaced thyroid feels like (palpitations, anxiety, heat intolerance, trouble sleeping), because those symptoms overlap with things people attribute to the GLP-1 itself. Attributing everything to the new drug is the easy mistake when two things changed at once. The GLP-1 itself also raises resting heart rate a little, which a separate guide sets out.

Frequently Asked Questions

It is worth asking. Levothyroxine dose requirement tracks body weight, so losing a substantial amount can make a previously correct dose too high. The decision belongs with whoever manages your thyroid, but the question is a reasonable one to raise.
That testing did not change. Among 5,370 matched patients on stable levothyroxine, about 83% had a TSH test within a year of starting either a GLP-1 or an SGLT2 inhibitor, at a mean of around 130 days. That was identical in both groups, even though, as the authors note, the weight loss seen with GLP-1 therapy makes a dose adjustment more likely.
Not in absolute terms. The finding is not that monitoring was poor but that it did not respond to a change in clinical need. Two situations that differ got the same pattern.
It has a separate one. Oral semaglutide taken with levothyroxine raised total thyroxine exposure by 33% in a dedicated trial. That is a pharmacokinetic effect that applies from the first dose, on top of any weight-related change.
Palpitations, anxiety, heat intolerance and difficulty sleeping. Those overlap with effects people attribute to the GLP-1 itself, which is the easy mistake to make when two things changed at once.

References

  1. 1.Chen Y, Du F, Singh Ospina NM, et al. Patterns of TSH test after GLP-1 RAs initiation in patients on levothyroxine: a trial emulation study The Journal of Clinical Endocrinology and Metabolism. 2026. PMID: 41902399.

GLP-1s and Your Other Medications: What Actually Interacts

Digoxin, warfarin and oral contraceptives came through interaction studies needing no dose adjustment. The warfarin problem is real but dietary, and taking other pills with oral semaglutide cuts its absorption by 34%.

7 min read

The Drugs That Are Not Here Yet

Four investigational molecules have published human results. The most striking figure among them, 8% of body weight in four weeks, comes from the earliest and smallest study of the four.

8 min read

Compounded GLP-1s and the Adverse Event Reports

A FAERS study found more adverse event reports for compounded GLP-1s. Reports are voluntary and there is no denominator, but one finding survives that critique: preparation and prescribing errors were reported more often for compounded products, while dosing errors were reported less often.

6 min read

Does Semaglutide Slow Aging? What the Longevity Evidence Shows

No trial has tested whether semaglutide slows aging. SELECT and FLOW found fewer deaths from any cause in people with heart or kidney disease, and the only aging-clock result is a post hoc 32-week analysis in 84 people with HIV.

11 min read

HCG, B12 and Lipotropic Shots: What the Labels and the FDA Say

HCG's own FDA-approved labeling states there is no substantial evidence it increases weight loss beyond caloric restriction. The 500-calorie diet it is sold with is the part that works, and the part that is dangerous.

6 min read

GLP-1 Drugs and Parkinson's Disease: What LIXIPARK and Exenatide-PD3 Showed

A 2024 phase 2 trial of lixisenatide found less motor decline over a year in early Parkinson's. The 2025 phase 3 Exenatide-PD3 trial found none over two years, and a pooled analysis of four trials found no benefit. Semaglutide and tirzepatide are untested.

7 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.3

Embody

A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies

6.4

Bodybuilding Health+

Seeing what it charges before you answer any medical questions

9.0

YourEra

Semaglutide at $99/month, well below the typical price

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →